mezlocillin has been researched along with cefuroxime in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (72.73) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 2 (9.09) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Boemi, P; Cilano, L; Platania, R; Reitano, S; Rizzari, G | 1 |
| Dickinson, IK; Griggs, NJ; Kelleher, JP; Moat, N; Rimmer, DM; Stubbs, RS | 1 |
| Cann, KJ; Crawfurd, E; George, C; Payne-James, J; Rogers, TR; Watkins, RM | 1 |
| Diamond, T; Hanna, WA; Mulholland, CK; Parks, TG | 1 |
| Popović, M; Stefanović, D; Vranes, M; Vujadinović, B | 1 |
| Good, RC; Shepard, CC; Van Landingham, RM; Walker, LL | 1 |
| Barba, D; Esposito, S; Galante, D | 1 |
| Ambrose, NS; Burdon, DW; Keighley, MR | 1 |
| Burdon, DW; Keighley, MR; Morris, DL; Young, D | 1 |
| Hofstra, H; van der Waaij, D; Wiegersma, N | 1 |
| Nuri, M; Peters, HJ; Weissbach, L | 1 |
| García-Iglesias, MC; Palomares, JC; Perea, EJ | 1 |
| Grimm, H | 1 |
| Marklein, G | 1 |
| Ambrose, NS; Burdon, DW; Keighley, MR; Morris, DL | 1 |
| Lindenschmidt, EG; Schassan, HH | 1 |
| Haller, IE; Heisler, S; Helmke, C; Hunger, R; Kirbach, J; Kobelt, E; Lünse, S; Mantke, R; Meyer, J; Paasch, C; Schildberg, C | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
8 trial(s) available for mezlocillin and cefuroxime
| Article | Year |
|---|---|
[Mezlocillin in short-term obstetrico-gynecologic prophylaxis].
Topics: Adolescent; Adult; Aged; Cefuroxime; Cephalosporins; Cesarean Section; Clinical Trials as Topic; Drug Evaluation; Female; Genitalia, Female; Gynecology; Humans; Mezlocillin; Middle Aged; Obstetrics; Pregnancy; Premedication; Time Factors | 1989 |
Single dose mezlocillin versus three dose cefuroxime plus metronidazole for the prophylaxis of wound infection after large bowel surgery.
Topics: Adult; Aged; Aged, 80 and over; Cefuroxime; Cephalosporins; Clinical Trials as Topic; Colon; Drug Therapy, Combination; Female; Humans; Intestine, Large; Male; Metronidazole; Mezlocillin; Middle Aged; Premedication; Prospective Studies; Random Allocation; Rectum; Surgical Wound Infection | 1987 |
A trial of mezlocillin versus cefuroxime with or without metronidazole for the prevention of wound sepsis after biliary and gastrointestinal surgery.
Topics: Biliary Tract Diseases; Cefuroxime; Cephalosporins; Clinical Trials as Topic; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Male; Metronidazole; Mezlocillin; Prospective Studies; Random Allocation; Surgical Wound Infection | 1988 |
A prospective randomized trial to compare triple dose mezlocillin with triple dose cefuroxime plus metronidazole as prophylaxis in colorectal surgery.
Topics: Adult; Aged; Aged, 80 and over; Cefuroxime; Cephalosporins; Clinical Trials as Topic; Colonic Diseases; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Mezlocillin; Middle Aged; Premedication; Prospective Studies; Random Allocation; Rectal Diseases; Surgical Wound Infection | 1988 |
A prospective randomized trial to compare mezlocillin and metronidazole with cefuroxime and metronidazole as prophylaxis in elective colorectal operations.
Topics: Adolescent; Adult; Aged; Cefuroxime; Cephalosporins; Clinical Trials as Topic; Clostridium; Colon; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Mezlocillin; Middle Aged; Premedication; Pseudomonas aeruginosa; Random Allocation; Rectum; Surgical Wound Infection | 1983 |
Prospective randomized trial of single dose cefuroxime against mezlocillin in elective gastric surgery.
Topics: Abscess; Cefuroxime; Cephalosporins; Clinical Trials as Topic; Humans; Mezlocillin; Penicillin Resistance; Premedication; Prospective Studies; Pseudomonas Infections; Staphylococcal Infections; Stomach; Surgical Wound Infection | 1984 |
[Mezlocillin versus cefuroxime in urinary tract infections. A multicenter clinical study].
Topics: Adult; Aged; Cefuroxime; Cephalosporins; Clinical Trials as Topic; Female; Humans; Male; Mezlocillin; Middle Aged; Penicillins; Recurrence; Time Factors; Urinary Tract Infections | 1982 |
Evaluation of mezlocillin in elective gastrointestinal surgery.
Topics: Cefuroxime; Clinical Trials as Topic; Clostridium Infections; Colon; Digestive System Surgical Procedures; Humans; Mezlocillin; Premedication; Rectum | 1983 |
14 other study(ies) available for mezlocillin and cefuroxime
| Article | Year |
|---|---|
[Comparative study of the value of a single dose of mezlocillin versus continuous therapy with cefuroxime-garamycin in the prevention of infection in cardiovascular surgery].
Topics: Cardiac Surgical Procedures; Cefuroxime; Cephalosporins; Drug Therapy, Combination; Gentamicins; Humans; Infection Control; Mezlocillin; Postoperative Complications; Premedication; Prospective Studies; Vascular Surgical Procedures | 1988 |
Activity of selected beta-lactam antibiotics against Mycobacterium leprae.
Topics: Animals; Anti-Bacterial Agents; Cefoxitin; Cefuroxime; Cephalosporins; Female; Leprosy; Mezlocillin; Mice; Mycobacterium leprae; Penicillins | 1987 |
In vitro microbiological properties of mezlocillin compared with four cephalosporins.
Topics: Bacteria; beta-Lactamases; Cefotaxime; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Hydrolysis; Mezlocillin; Microbial Sensitivity Tests; Mutation | 1986 |
Effect of beta-lactam antibiotics of the resistance of the digestive tract of mice to colonization.
Topics: Animals; Anti-Bacterial Agents; Azlocillin; beta-Lactams; Cefuroxime; Cephamycins; Dose-Response Relationship, Drug; Enterobacter; Enterobacteriaceae; Enterococcus faecalis; Escherichia coli; Feces; Female; Intestines; Mezlocillin; Mice; Moxalactam; Penicillins | 1982 |
In vitro evaluation of new penicillins and cephalosporins upon P. aeruginosa and their interaction with mecillinam.
Topics: Amdinocillin; Azlocillin; Carbenicillin; Cefamandole; Cefoxitin; Cefsulodin; Cefuroxime; Cephalosporins; Culture Media; Drug Synergism; Mezlocillin; Penicillanic Acid; Penicillins; Pseudomonas aeruginosa; Pyocins; Ticarcillin | 1980 |
[Bacteriological in vitro studies with a new cephalosporin: cefotiam (author's transl)].
Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Cefotiam; Cefoxitin; Cefuroxime; Lactams; Mezlocillin; Microbial Sensitivity Tests; Penicillins | 1981 |
[Chemotherapy of listeriosis (author's transl)].
Topics: Ampicillin; Cefamandole; Cefotaxime; Cefoxitin; Cefuroxime; Doxycycline; Gentamicins; Humans; Listeriosis; Mezlocillin; Microbial Sensitivity Tests; Penicillins; Piperacillin | 1982 |
[Fosfomycin, a new antibiotic: in vitro activity compared with mezlocillin, cefuroxime and gentamicin].
Topics: Animals; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Enterobacteriaceae; Fosfomycin; Gentamicins; In Vitro Techniques; Mezlocillin; Penicillin Resistance; Penicillins; Pseudomonadaceae; Staphylococcus | 1980 |
Optimal timing for antimicrobial prophylaxis to reduce surgical site infections: a retrospective analysis of 531 patients.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Cefuroxime; Colorectal Neoplasms; Humans; Metronidazole; Mezlocillin; Piperacillin; Retrospective Studies; Sulbactam; Surgical Wound Infection; Tazobactam | 2023 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |